Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting No phase listed Observational

An Observational Study of the Progression of Intermediate Age-Related Macular Degeneration

ClinicalTrials.gov ID: NCT05300724

Public ClinicalTrials.gov record NCT05300724. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 4:37 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Prospective, Observational Study of the Progression of Intermediate Age-Related Macular Degeneration

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a multicenter prospective study in participants with intermediate age-related macular degeneration (iAMD). One primary objective of this study is to assess iAMD disease progression, by the timeline and rates of conversion for high-risk iAMD at baseline to more advanced atrophic AMD stages. The other primary objective of this observational study is to assess the feasibility of measuring the rate of photoreceptor loss as a potential clinical endpoint. The study will consist of an observation period of approximately 3 years (\~144 weeks) for participants.

Study identification

NCT ID
NCT05300724
Recruitment status
Active, not recruiting
Study type
Observational
Phase
Not listed
Lead sponsor
Genentech, Inc.
Industry
Enrollment
400 participants

Conditions and interventions

Interventions

Other

Eligibility (public fields only)

Age range
50 Years to 94 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 27, 2022 (Actual)
Primary completion
Jun 30, 2027 (Estimated)
Completion
Jun 30, 2027 (Estimated)
Last update posted
Sep 16, 2026

2022 – 2027

United States locations

U.S. sites
46
U.S. states
27
U.S. cities
43
Facility City State ZIP Site status
Retina Partners of Northwest Arkansas, PLLC Springdale Arkansas 72764 —
The Retina Partners Encino California 91436-2018 —
Retina Consultants of Orange County Fullerton California 92835 —
Northern California Retina Vitreous Associates Mountain View California 94040 —
Retina Consultants, San Diego Poway California 92064 —
UC Davis Eye Center Sacramento California 95817 —
Retinal Consultants Medical Group Sacramento California 95841-2013 —
Bay Area Retina Associates Walnut Creek California 94598 —
Southwest Retina Consultants Durango Colorado 81303 —
Eye Care Center of Northern Colorado PC Longmont Colorado 80503 —
Advanced Research Coral Springs Florida 33067 —
Rand Eye Institute Deerfield Beach Florida 33064 —
National Ophthalmic Research Institute Fort Myers Florida 33912 —
Florida Eye Associates Melbourne Florida 32901 —
Southeast Retina Center Augusta Georgia 30909 —
University Retina and Macula Associates, PC Oak Forest Illinois 60452 —
Raj K. Maturi, MD PC Indianapolis Indiana 46290 —
Wolfe Eye Clinic West Des Moines Iowa 50266 —
Cumberland Valley Retina Consultants PC Hagerstown Maryland 21740 —
New England Retina Consultants Springfield Massachusetts 01107 —
Foundation for Vision Research Grand Rapids Michigan 49546 —
Deep Blue Retina Clinical Research Southaven Mississippi 38671 —
Sierra Eye Associates Reno Nevada 89502 —
Eye Associates of New Mexico Albuquerque New Mexico 87109 —
Vitreous Retina Macula Consultants of New York New York New York 10022 —
Ophthalmic Consultants of Long Island Rockville Centre New York 11570 —
Duke Eye Center Durham North Carolina 27705 —
Cleveland Clinic Cole Eye Institute Cleveland Ohio 44195 —
Retina Vitreous Center Edmond Oklahoma 73013 —
EyeHealth Northwest Portland Oregon 97224 —
Casey Eye Institute - OHSU Portland Oregon 97239 —
Erie Retinal Surgery Erie Pennsylvania 16507 —
Scheie Eye Institute Philadelphia Pennsylvania 19104 —
Palmetto Retina Center, LLC West Columbia South Carolina 29169 —
Tennessee Retina PC Nashville Tennessee 37203 —
W Texas Retina Consultants PA Abilene Texas 79606 —
Austin Retina Associates Austin Texas 78705 —
Austin Clinical Research LLC Austin Texas 78750 —
Retina Consultants of Texas Bellaire Texas 77401 —
Retina Foundation of the Southwest Dallas Texas 75231 —
Retina Specialists DeSoto Texas 75115 —
San Antonio Eye Center San Antonio Texas 78215 —
Rocky Mountain Retina Salt Lake City Utah 84107 —
Wagner Kapoor Institute Norfolk Virginia 23502 —
Spokane Eye Clinical Research Spokane Washington 99204 —
University of Wisconsin Hospital and Clinics Madison Wisconsin 53705-2275 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 28 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05300724, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 16, 2026 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05300724 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →